Correlation Between Edesa Biotech and Elicio Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edesa Biotech and Elicio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edesa Biotech and Elicio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edesa Biotech and Elicio Therapeutics, you can compare the effects of market volatilities on Edesa Biotech and Elicio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edesa Biotech with a short position of Elicio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edesa Biotech and Elicio Therapeutics.

Diversification Opportunities for Edesa Biotech and Elicio Therapeutics

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Edesa and Elicio is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Edesa Biotech and Elicio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elicio Therapeutics and Edesa Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edesa Biotech are associated (or correlated) with Elicio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elicio Therapeutics has no effect on the direction of Edesa Biotech i.e., Edesa Biotech and Elicio Therapeutics go up and down completely randomly.

Pair Corralation between Edesa Biotech and Elicio Therapeutics

Given the investment horizon of 90 days Edesa Biotech is expected to under-perform the Elicio Therapeutics. In addition to that, Edesa Biotech is 1.34 times more volatile than Elicio Therapeutics. It trades about -0.43 of its total potential returns per unit of risk. Elicio Therapeutics is currently generating about 0.09 per unit of volatility. If you would invest  478.00  in Elicio Therapeutics on August 23, 2024 and sell it today you would earn a total of  34.00  from holding Elicio Therapeutics or generate 7.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Edesa Biotech  vs.  Elicio Therapeutics

 Performance 
       Timeline  
Edesa Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Edesa Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Elicio Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Elicio Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Elicio Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Edesa Biotech and Elicio Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edesa Biotech and Elicio Therapeutics

The main advantage of trading using opposite Edesa Biotech and Elicio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edesa Biotech position performs unexpectedly, Elicio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elicio Therapeutics will offset losses from the drop in Elicio Therapeutics' long position.
The idea behind Edesa Biotech and Elicio Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
CEOs Directory
Screen CEOs from public companies around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.